Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic

Qu, YM; Lipkovich, I

Qu, YM (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.; Qu, YM (corresponding author), Eli Lilly & Co, Dept Data & Analyt, Lilly Corp Ctr, Indianapolis, IN 46285 USA.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021; 55 (5): 984